Innovid Statistics
Total Valuation
Innovid has a market cap or net worth of $324.77 million. The enterprise value is $291.19 million.
| Market Cap | 324.77M |
| Enterprise Value | 291.19M |
Important Dates
The next confirmed earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Innovid has 141.82 million shares outstanding. The number of shares has increased by 5.98% in one year.
| Shares Outstanding | 141.82M |
| Shares Change (YoY) | +5.98% |
| Shares Change (QoQ) | +0.88% |
| Owned by Insiders (%) | 16.82% |
| Owned by Institutions (%) | 46.34% |
| Float | 94.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.28 |
| Forward PS | 2.02 |
| PB Ratio | 1.63 |
| P/FCF Ratio | 150.09 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 136.96 |
Financial Position
The company has a current ratio of 3.99, with a Debt / Equity ratio of 0.11.
| Current Ratio | 3.99 |
| Quick Ratio | 3.77 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | 10.27 |
| Interest Coverage | 9.64 |
Financial Efficiency
Return on equity (ROE) is -16.30% and return on invested capital (ROIC) is -15.13%.
| Return on Equity (ROE) | -16.30% |
| Return on Assets (ROA) | -12.80% |
| Return on Capital (ROIC) | -15.13% |
| Revenue Per Employee | $300,176 |
| Profits Per Employee | -$68,479 |
| Employee Count | 466 |
| Asset Turnover | 0.56 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Innovid has paid $2.37 million in taxes.
| Income Tax | 2.37M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +126.84% in the last 52 weeks. The beta is 3.32, so Innovid's price volatility has been higher than the market average.
| Beta (1Y) | 3.32 |
| 52-Week Price Change | +126.84% |
| 50-Day Moving Average | 2.10 |
| 200-Day Moving Average | 1.48 |
| Relative Strength Index (RSI) | 50.01 |
| Average Volume (30 Days) | 300,395 |
Short Selling Information
The latest short interest is 355,922, so 0.25% of the outstanding shares have been sold short.
| Short Interest | 355,922 |
| Short Previous Month | 296,940 |
| Short % of Shares Out | 0.25% |
| Short % of Float | 0.38% |
| Short Ratio (days to cover) | 0.98 |
Income Statement
In the last 12 months, Innovid had revenue of $139.88 million and -$31.91 million in losses. Loss per share was -$0.23.
| Revenue | 139.88M |
| Gross Profit | 106.08M |
| Operating Income | -32.96M |
| Pretax Income | -29.54M |
| Net Income | -31.91M |
| EBITDA | -19.96M |
| EBIT | -32.96M |
| Loss Per Share | -$0.23 |
Balance Sheet
The company has $49.75 million in cash and $21.83 million in debt, giving a net cash position of $27.92 million or $0.20 per share.
| Cash & Cash Equivalents | 49.75M |
| Total Debt | 21.83M |
| Net Cash | 27.92M |
| Net Cash Per Share | $0.20 |
| Equity / Book Value | 195.99M |
| Book Value Per Share | 1.38 |
| Working Capital | 76.12M |
Cash Flow
In the last 12 months, operating cash flow was $12.44 million and capital expenditures -$10.31 million, giving a free cash flow of $2.13 million.
| Operating Cash Flow | 12.44M |
| Capital Expenditures | -10.31M |
| Free Cash Flow | 2.13M |
| FCF Per Share | $0.02 |
Margins
Gross margin is 75.83%, with operating and profit margins of -23.56% and -22.81%.
| Gross Margin | 75.83% |
| Operating Margin | -23.56% |
| Pretax Margin | -21.12% |
| Profit Margin | -22.81% |
| EBITDA Margin | -14.27% |
| EBIT Margin | -23.56% |
| FCF Margin | 1.52% |
Dividends & Yields
Innovid does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.98% |
| Shareholder Yield | -5.98% |
| Earnings Yield | -10.00% |
| FCF Yield | 0.67% |
Analyst Forecast
The average price target for Innovid is $2.45, which is 6.99% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.45 |
| Price Target Difference | 6.99% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Innovid has an Altman Z-Score of 3.01 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.01 |
| Piotroski F-Score | 4 |